論文

国際誌
2022年12月1日

Association Between Alberta Stroke Program Early Computed Tomography Score and Efficacy and Safety Outcomes With Endovascular Therapy in Patients With Stroke From Large-Vessel Occlusion: A Secondary Analysis of the Recovery by Endovascular Salvage for Cer

JAMA neurology
  • Uchida, Kazutaka
  • Shindo, Seigo
  • Yoshimura, Shinichi
  • Toyoda, Kazunori
  • Sakai, Nobuyuki
  • Yamagami, Hiroshi
  • Matsumaru, Yuji
  • Matsumoto, Yasushi
  • Kimura, Kazumi
  • Ishikura, Reiichi
  • Yoshida, Astushi
  • Inoue, Manabu
  • Beppu, Mikiya
  • Sakakibara, Fumihiro
  • Shirakawa, Manabu
  • Morimoto, Takeshi
  • RESCUE-Japan LIMIT Investigators
  • 全て表示

79
12
開始ページ
1260
終了ページ
1266
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1001/jamaneurol.2022.3285

[IMPORTANCE] Endovascular therapy (EVT) has been found to reduce functional disability in patients with acute stroke due to large-vessel occlusion. However, the extent of the ischemic region, measured using Alberta Stroke Program Early Computed Tomography Scores, may limit the efficacy of EVT.
[OBJECTIVE] To compare the efficacy and safety of EVT according to ASPECTS 3 or less vs 4 to 5.
[DESIGN, SETTING, AND PARTICIPANTS] The Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism-Japan Large Ischemic Core Trial (RESCUE-Japan LIMIT) was an open-label randomized clinical trial conducted from November 2018 to December 2021 at 45 stroke centers across Japan. The trial enrolled adult patients with acute ischemic stroke with a large ischemic region, defined as ASPECTS 3 to 5 primarily determined by magnetic resonance imaging, with occlusion site at the internal carotid artery or middle cerebral artery segment 1. Among 203 enrolled patients, 1 withdrew consent and 202 were included in the original trial and secondary analysis. This secondary analysis was conducted in April 2022.
[INTERVENTIONS] Patients were randomly assigned to EVT with medical therapy or medical therapy alo

リンク情報
DOI
https://doi.org/10.1001/jamaneurol.2022.3285
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/36215044
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552045
ID情報
  • DOI : 10.1001/jamaneurol.2022.3285
  • ISSN : 2168-6157
  • PubMed ID : 36215044
  • PubMed Central 記事ID : PMC9552045

エクスポート
BibTeX RIS